核心观点:生物制品:本周南北方流感病毒检测阳性率上升,主要流行毒株为A(H3N2)亚型,建议关注流感疫苗接种及相关产业链机会,同时跟踪疫苗销售改善与创新管线研发及授权进展。医药商业:1)药店行业:头部药店经营企稳,估值处于历史低位。短期关注需求回暖、行业集中度提升及门诊统筹政策增量。长期看,头部药店开展转型试点,期待26年探索可行路径并贡献增量。2)流通行业:头部公司经营企稳,未来关注回款改善及...
Source Link核心观点:生物制品:本周南北方流感病毒检测阳性率上升,主要流行毒株为A(H3N2)亚型,建议关注流感疫苗接种及相关产业链机会,同时跟踪疫苗销售改善与创新管线研发及授权进展。医药商业:1)药店行业:头部药店经营企稳,估值处于历史低位。短期关注需求回暖、行业集中度提升及门诊统筹政策增量。长期看,头部药店开展转型试点,期待26年探索可行路径并贡献增量。2)流通行业:头部公司经营企稳,未来关注回款改善及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.